Trial
NCT01403389
A Study of the Activity of Eculizumab for Prevention of Delayed Graft Function In Deceased Donor Kidney Transplant
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Schroppel, Bernd, M.D.
Collaborators
Alexion Pharmaceuticals, Inc.
Condition
Delayed Function of Renal Transplant
Intervention
Eculizumab
Why stopped
After interim analysis, the pilot study was terminated and modified to a larger multicenter study (NCT01919346) to better assess efficacy.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-05-06